Pharmaceutical Outsourcing Evolution: The Rise of Clinical Peripheral Services
Frost & Sullivan
MAY 9, 2025
The Expanding Role of Clinical Contract Peripheral Services As the pharmaceutical and biopharma industries recalibrate after the COVID-19 pandemic, clinical trial outsourcing has surged, creating significant opportunities for contract research organizations (CROs). billion in 2024, is projected to grow at a CAGR of 10.7%, reaching $122.13
Let's personalize your content